Mid Pharmaceuticals

Mankind Pharma Ltd.

MANKIND

Market Cap
₹1,01,632 Cr.
P/E
53.13

Mankind Pharma Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
1.02 L Cr
PE
PE
53.13
Prom Holding
Prom Holding
72.66 %
ROE (%)
ROE (%)
13.89
ROCE (%)
ROCE (%)
13.35
Div Yield (%)
Div Yield (%)
-
Sales
Sales
14,277 Cr
OPM (%)
OPM (%)
25.34 %
Debt to Equity
Debt to Equity
0.58
Institutions
Institutions
24.66 %
Individual < 2 lac
Individual < 2 lac
1.34 %
No. of Shareholders
No. of Shareholders
1.78 L
View more
Edit Ratio's

About

Mankind Pharma is a leading Indian pharmaceutical company with a diverse portfolio spanning ph… Read more
Low
1910
52W Range
High
2717
  • Mankind Pharma
  • Lupin
  • Zydus Lifesciences

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

3 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share

0 %
(as of Mar 22)
Historic
Anti Fungal Antibiotics (Terbinaforce) - Market Share
0 %
(as of Mar 22)
Historic
Anti-Hypertensives (Amolkind-AT) Market Share
60 %
(as of Jun 23)
Historic
Birth Control (Unwanted-72) - Market Share
0 %
(as of Mar 21)
Historic
Depression (Placida) - Market Share
0 %
(as of Mar 21)
Historic
Gastrointestinal (Nurokind-LC) - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Location Wise Break-Up - Domestic Sales

Acute vs Chronic

Brand Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • Advertisement Spend as a % of Total Sales (%)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Acne Star
    Manforce
    Preganews
    Unwanted72

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Mankind Pharma Ltd. Business

    Mankind Pharma is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&amp;D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

    Mankind Pharma major competitors are Lupin, Zydus Lifesciences, Dr. Reddy's Labs., Cipla, Aurobindo Pharma, Alkem Laboratories, Glenmark Pharma..
    Market Cap of Mankind Pharma is ₹1,02,256 Crs.
    While the median market cap of its peers are ₹1,08,264 Crs.

    Mankind Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May Jul Nov Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Feb May May Jul Nov Mar Jun Sep Dec Jan Mar Jun Sep Dec
    Conference Call Feb May Mar Jun Nov Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Mankind Pharma Ltd.
    Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? - Nikhil Kamath
    Interview With Mankind’s Founder Rajeev Juneja - Ranveer Allahbad
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material